Top Markets
#1 Black Phoenix Black Phoenix +342.75%
#2 Glidr Glidr +84.34%
#3 Akedo Akedo +61.75%
#4 Gold Park Gold Park +55.03%
#5 Acurast Acurast +36.76%
#6 BasedHype BasedHype +29.66%
#7 Cryptopia Cryptopia +22.04%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.03%
#9 Avantis Avantis +18.81%
#10 Quantum Resistant Ledger Quantum Resistant Ledger +14.74%
Coin of the day
Black Phoenix Black Phoenix
設定
言語
日本
通貨
USD
テーマ
Nunzia Pharmaceutical Company Nunzia Pharmaceutical Company

Nunzia Pharmaceutical Company

NUNZ
株式のランク #41103
Nunzia Pharmaceutical Company operates as a pharmaceutical and nutraceutical... Nunzia Pharmaceutical Company operates as a pharmaceutical and nutraceutical company. The company owns the right to manufacture, market, and distribute Nunzia, a nutraceutical that treats autism, fragile X, ADHD, PTSD, and other disorders. It offers its products through wholesalers, as well as through its website nunziapharma.com. The company was formerly known as Arizona Gold and Onyx Mining Company and changed its name to Nunzia Pharmaceutical Company in February 2018. Nunzia Pharmaceutical Company was incorporated in 1986 and is based in Long Beach, California.
株価
$0.0001
最終同期: 2026-08-12
時価総額
$43.45K
変化（1日）
0.00%
変化（1年）
-96.67%
国
US
取引 Nunzia Pharmaceutical Company (NUNZ)

カテゴリー

Healthcare
Nunzia Pharmaceutical Company（NUNZ）の配当利回りの履歴
Nunzia Pharmaceutical Company（銘柄コード: NUNZ）の配当利回り（TTM）は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Nunzia Pharmaceutical Company（NUNZ）の2026から2026までの配当利回りの履歴
各年末時点の配当利回り（TTM）
年 配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り（TTM）
企業 配当利回り 国
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
1.56%
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
0.00%
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
0.00%
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
0.00%
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
0.00%
US